Internal Medicine, Endocrinology, Diabetes, & Metabolism · Mayaguez, PR
NPI
1134221724
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
114 Calle McKinley W, Suite 208 Yaguez Medical Plaza
Mayaguez, PR, 00680
Phone (787) 805-5435
Medicare paid, 2024
$6,314
105 services
Medicare patients, 2024
50
Average age 77
Drug cost, 2024
$4.5M
26,204 prescriptions
Company payments, 2025
$98.95
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Denise Caro was code 99214 (office e&m - established), 48 times for 25 patients. In total Denise Caro billed 105 services in 5 codes, and Medicare paid $6,314.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 48 | 25 | $74.02 | $3,553 |
| 99213 Office E&M - Established | Office | 47 | 28 | $53.13 | $2,497 |
By year: 2022 $8,478 for 142 services; 2023 $5,267 for 100 services; 2024 $6,314 for 105 services.
Medicare prescription drug claims, 2024
In 2024, the drug Denise Caro prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 3,139 prescriptions and refills. In total Denise Caro wrote 26,204 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 3,139 | 7,311 | 745 | $318K |
| Rosuvastatin Calcium Generic | 1,511 | 3,800 | 462 | $21K |
| Farxiga Dapagliflozin Propanediol | 1,302 | 1,614 | 234 | $941K |
| Glimepiride Generic | 1,046 | 2,527 | 301 | $25K |
| Atorvastatin Calcium Generic | 953 | 2,432 | 298 | $11K |
| Levothyroxine Sodium Generic | 923 | 2,403 | 276 | $14K |
| Metformin Hcl Generic | 912 | 2,131 | 267 | $7,153 |
| Losartan Potassium Generic | 797 | 2,042 | 246 | $10K |
| Jardiance Empagliflozin | 637 | 779 | 116 | $477K |
| Gabapentin Generic | 603 | 1,354 | 172 | $9,296 |
| Amlodipine Besylate Generic | 487 | 1,173 | 154 | $3,099 |
| Trulicity Dulaglutide | 421 | 448 | 61 | $445K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 399 | 504 | 72 | $42K |
| Levoxyl Levothyroxine Sodium | 382 | 843 | 85 | $19K |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 378 | 460 | 65 | $47K |
Brand drugs: 10,184 claims; generic drugs: 15,327 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Denise Caro $98.95 ($98.95 in general payments such as food, travel and fees) from 3 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $50.52.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.